Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722107 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
ElectronicAdd to Basket



Commercial and Pipeline Insight: Allergic Rhinitis
Datamonitor, Oct 2007, Pages: 319

  Description  
  Table of Contents  

  Companies Mentioned  
    
    
   
 Enquire before Buying  
 Send to a Friend  

- ALK-Abelló
- Allergopharma
- Allergy Therapeutics
- CMP Therapeutics
- Cobalis
- Curalogic
- Cytos Biotechnology
- Dynavax
- Fornix Biosciences
- GlaxoSmithKline
- Greer Laboratories
- HAL Allergy
- Merck & Co
- Pfizer
- Sanofi-Aventis
- Schering-Plough
- Sepracor
- Stallergènes
- UCB


Customers who bought this item also bought

The Asthma, COPD & Allergic Rhinitis Market Outlook to 2011

Strategic Perspectives: Allergic Rhinitis - Impact of a blockbuster going bust

Commercial and Stakeholder Perspectives: Allergic Rhinitis - Is There Life After Claritin?

Allergic Rhinitis Opinion Leader Forum, 2002

Market Dynamics 2000: Allergic Rhinitis: Effects of Major Patent Expiries On An Expanding Market

Pipeline Insight: Asthma, Copd and Allergic Rhinitis - The Needs of Severe Patients Must be Addressed

Immunotherapy in Allergic Rhinitis - Moving Away from Injections

Rigels Allergic Rhinitis Candidate - R112

Pipeline Insight: Asthma, COPD and Allergic Rhinitis - Weak Late Stage Pipeline Leaves Innovation to Phase I/II Candidates

Pipeline Insight: Asthma/COPD/Allergic Rhinitis - As Patents Expire, Novel Combinations Inspire

Treatment Algorithms 2001: Allergic Rhinitis - Unlocking the Real Patient Potential

Drugs of Tomorrow 2000: Allergic Rhinitis - New Drug Classes, Towards Total Disease Management
Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds